96 related articles for article (PubMed ID: 3976767)
1. Antibodies to the neutral glycolipid asialo ganglio-N-tetraosylceramide: association with gynecologic cancers.
Witkin SS; Bongiovanni AM; Birnbaum S; Caputo T; Ledger WJ
Am J Obstet Gynecol; 1985 Mar; 151(5):679-81. PubMed ID: 3976767
[TBL] [Abstract][Full Text] [Related]
2. Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS).
Witkin SS; Sonnabend J; Richards JM; Purtilo DT
Clin Exp Immunol; 1983 Nov; 54(2):346-50. PubMed ID: 6652964
[TBL] [Abstract][Full Text] [Related]
3. Ganglio-N-tetraosylceramide (asialo GM1), an antigen common to the brain and immune system: its localization in myelin.
Kusunoki S; Tsuji S; Nagai Y
Brain Res; 1985 May; 334(1):117-24. PubMed ID: 2581667
[TBL] [Abstract][Full Text] [Related]
4. Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells.
Young WW; Hakomori SI; Durdik JM; Henney CS
J Immunol; 1980 Jan; 124(1):199-201. PubMed ID: 6985637
[TBL] [Abstract][Full Text] [Related]
5. Morphology and function of ganglio-N-tetraosylceramide-positive lymphocyte mediators of natural killer activity.
Shimamura K; Habu S; Fukui H; Akatsuka A; Okumura K; Tamaoki N
J Natl Cancer Inst; 1982 Mar; 68(3):449-55. PubMed ID: 6950172
[TBL] [Abstract][Full Text] [Related]
6. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
[TBL] [Abstract][Full Text] [Related]
7. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
Young WW; MacDonald EM; Nowinski RC; Hakomori SI
J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.
Kannagi R; Stroup R; Cochran NA; Urdal DL; Young WW; Hakomori S
Cancer Res; 1983 Oct; 43(10):4997-5005. PubMed ID: 6860431
[TBL] [Abstract][Full Text] [Related]
9. Display of the neutral glycolipid ganglio-n-tetraosylceramide (asialo GM1) on cells of the natural killer and T lineages.
Beck BN; Gillis S; Henney CS
Transplantation; 1982 Feb; 33(2):118-22. PubMed ID: 6977214
[TBL] [Abstract][Full Text] [Related]
10. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
11. Asialo GM1-positive cells in mouse cochlea.
Iguchi H; Yamane H; Konishi K; Nakagawa T; Shibata S; Takayama M; Nishimura K; Sunami K; Nakai Y
Acta Otolaryngol Suppl; 1997; 528():6-9. PubMed ID: 9288228
[TBL] [Abstract][Full Text] [Related]
12. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
Suzuki S; Suzuki R; Onta T; Kumagai K
Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
[TBL] [Abstract][Full Text] [Related]
13. The glycolipid asialo GM1 as a new differentiation antigen of fetal thymocytes.
Habu S; Kasai M; Nagai Y; Tamaoki N; TAda T; Herzenberg LA; Okumura K
J Immunol; 1980 Nov; 125(5):2284-8. PubMed ID: 6968778
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE.
Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM
J Immunol; 1984 Apr; 132(4):1793-7. PubMed ID: 6699401
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
16. IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Int J Cancer; 2000 Sep; 87(6):824-8. PubMed ID: 10956393
[TBL] [Abstract][Full Text] [Related]
17. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
[TBL] [Abstract][Full Text] [Related]
18. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
20. Liposome agglutination and liposomal membrane immune-damage assays for the characterization of antibodies to glycosphingolipids.
Uemura K; Yuzawa-Watanabe M; Kitazawa N; Taketomi T
J Biochem; 1980 Jun; 87(6):1641-8. PubMed ID: 7190563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
